Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Xencor (XNCR) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (60)	12/17/2014 12:15:18 PM
From: mopgcw	Read Replies (1) \| Respond to of 136

thanks for sharing, I only have a small lot, toe in the water so to speak. not sure I want to be out of it ahead of RA or not. argh. toughest of choices. chips today... hope all is well with you.

To: scaram(o)uche who wrote (60)	12/17/2014 7:58:44 PM
From: fitzdad55	Read Replies (2) \| Respond to of 136

Did so as well (at about the same time!) when the share price was about $15.25. Interesting to see it spike a bit higher a little later in the afternoon. Also interesting that this 30% increase occurred with no news seemingly available to the public. Assumed that it was a combination of factors: (1) strong day for the markets in wake of Fed mtg and update; (2) the recent MLV & Co.analyst upgrade to $18 and buy rating; (3) anticipation of very positive read out of P1a data for XmAb 5871 for RA (even though Xencor is not pursuing 5871 for RA). Impressive run up before data release!